Dermal fibroblasts from MAPT p.R406W carriers (F11362 and F11421) were transduced with non-integrating Sendai virus carrying OCT3/4, SOX2, KLF4, and cMYC (Life Technologies) as previously described [19 (link)]. iPSCs that were heterozygous for MAPT p.R406W were edited to WT (F11362.1Δ1B06 and F11421.12Δ2A07) using CRISPR/Cas9 as previously reported [19 (link), 39 ]. Mutation status was confirmed by Sanger sequencing (Supplemental Fig. 1). Cell lines were maintained in mTeSR medium (StemCell Technologies) on Matrigel. Cell lines were confirmed to be free of mycoplasma.
Free full text: Click here